University of Oklahoma Researchers Discover Hormone FGF21's Role in Obesity Reversal
Researchers at the University of Oklahoma have identified a hormone, FGF21 (fibroblast growth factor 21), that can reverse obesity in mice by acting on a specific brain region associated with appetite and metabolism. This discovery, published in Cell Reports, highlights the hormone's action on the hindbrain, particularly the nucleus of the solitary tract and the area postrema, which are crucial for regulating hunger and energy balance. Unlike other metabolic signals that target organs like the liver, FGF21 primarily influences the brain, offering a new perspective on obesity treatment. The study, led by Matthew Potthoff, Ph.D., suggests that FGF21 could lead to more targeted therapies for obesity and related conditions like MASH (metabolic dysfunction-associated steatohepatitis).